These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6375490)

  • 1. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
    Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study.
    Tubercle; 1991 Jun; 72(2):88-100. PubMed ID: 1949222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council].
    Chaulet P
    Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
    Tubercle; 1983 Sep; 64(3):153-66. PubMed ID: 6356538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present status of chemotherapy for tuberculosis.
    Grosset JH
    Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
    Cowie RL; Brink BA
    S Afr Med J; 1990 Apr; 77(8):390-1. PubMed ID: 2184527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.